<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Netvouz / lillymark / tag / bio-equivalence</title>
<link>http://netvouz.com/lillymark/tag/bio-equivalence?feed=rss</link>
<description>lillymark&#39;s bookmarks tagged &quot;bio-equivalence&quot; on Netvouz</description>
<item><title>Bioequivalence Studies</title>
<link>http://www.lotuslabs.com/en/bioequivalence.aspx</link>
<description>Lotus has a wide experience in conducting  bioequivalence studies for various regulatory authority submissions. Lotus has conducted more than 1300 bioequivalence studies including the bioavailability studies.  In bioequivalence studies the plasma concentration time curve is generally used to assess the rate and extent of absorption.</description>
<category domain="http://netvouz.com/lillymark?category=5038404302206526589"></category>
<author>lillymark</author>
<pubDate>Thu, 25 Apr 2013 08:26:59 GMT</pubDate>
</item><item><title>Bioequivalence Studies</title>
<link>http://lotuslabs.com/en/bioequivalence.aspx</link>
<description>Lotus has a wide experience in conducting  bioequivalence studies for various regulatory authority submissions. Lotus has conducted more than 1300 bioequivalence studies including the bioavailability studies.  In bioequivalence studies the plasma concentration time curve is generally used to assess the rate and extent of absorption.</description>
<category domain="http://netvouz.com/lillymark?category=5038404302206526589"></category>
<author>lillymark</author>
<pubDate>Tue, 08 Apr 2014 10:57:17 GMT</pubDate>
</item><item><title>Bioequivalence Studies</title>
<link>http://lotuslabs.com/en/bioequivalence.aspx</link>
<description>Lotus has a wide experience in conducting  bioequivalence studies for various regulatory authority submissions. Lotus has conducted more than 1300 bioequivalence studies including the bioavailability studies.  In bioequivalence studies the plasma concentration time curve is generally used to assess the rate and extent of absorption.</description>
<category domain="http://netvouz.com/lillymark?category=5038404302206526589"></category>
<author>lillymark</author>
<pubDate>Wed, 19 Jun 2013 06:27:12 GMT</pubDate>
</item><item><title>Dedicated Team for Bioequivalence Studies</title>
<link>http://www.lotuslabs.com/en/bioequivalence.aspx</link>
<description>At Lotus Labs Pvt. Ltd., the experience in Bioequivalence studies addresses various formulations including Solid oral formulation (IR, ER, MR and dispersible tablets) and liquid oral formulations like syrups and suspensions.</description>
<category domain="http://netvouz.com/lillymark?category=5038404302206526589"></category>
<author>lillymark</author>
<pubDate>Thu, 11 Jul 2013 07:19:26 GMT</pubDate>
</item><item><title>Dedicated Team for Bioequivalence Studies</title>
<link>http://lotuslabs.com/en/late-phase-clinical-trials.aspx</link>
<description>At Lotus Labs Pvt. Ltd., the experience in Bioequivalence studies addresses various formulations including Solid oral formulation (IR, ER, MR and dispersible tablets) and liquid oral formulations like syrups and suspensions.</description>
<category domain="http://netvouz.com/lillymark?category=5038404302206526589"></category>
<author>lillymark</author>
<pubDate>Thu, 22 Aug 2013 07:46:11 GMT</pubDate>
</item></channel></rss>